Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I/II study of THV02 in patients with adult T-cell Leukemia/Lymphoma.

Trial Profile

A phase I/II study of THV02 in patients with adult T-cell Leukemia/Lymphoma.

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 12 Feb 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs THV 02 (Primary)
  • Indications Adult T-cell leukaemia-lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors THERAVECTYS
  • Most Recent Events

    • 12 Feb 2015 New trial record
    • 04 Feb 2015 According to Theravectys media release, recruitment is planned to begin at the end of Q3 2015 in Europe and further proceed to the U.S and Japan in 2016.
    • 04 Feb 2015 According to Theravectys media release, European Medicines Agency (EMA) has granted Orphan Drug Designation to THV02 for the treatment of adult T-cell leukemia/lymphoma.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top